RT Journal Article
SR Electronic
T1 Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 5431
OP 5436
VO 36
IS 10
A1 TAKAAKI ARIGAMI
A1 YOSHIKAZU UENOSONO
A1 SUMIYA ISHIGAMI
A1 SHIGEHIRO YANAGITA
A1 KEISHI OKUBO
A1 YASUTO UCHIKADO
A1 YOSHIAKI KITA
A1 SHINICHIRO MORI
A1 HIROSHI KURAHARA
A1 KOSEI MAEMURA
A1 SHOJI NATSUGOE
YR 2016
UL http://ar.iiarjournals.org/content/36/10/5431.abstract
AB Aim: To compare adverse events and post-therapeutic clinical courses between stomach-partitioning gastrojejunostomy with Braun enteroenterostomy (SPGJ-BEE) and endoscopic metallic stent placement (EMSP) in patients with gastric outlet obstruction (GOO) caused by unresectable gastric cancer and assess the clinical utility of SPGJ-BEE. Patients and Methods: We retrospectively reviewed clinical data of 16 and 9 patients with GOO undergoing SPGJ-BEE and EMSP, respectively. Results: Re-obstruction caused by tumor overgrowth was identified in 3 (33.3%) out of 9 patients in the EMSP group. The GOO scoring system (GOOSS) revealed that its score after treatments was significantly higher in the SPGJ-BEE group than in the EMSP group (p<0.001). All patients in both groups received chemotherapy after treatments. The median survival times in the SPGJ-BEE and EMSP groups were 414 and 303 days, respectively. Conclusion: Our preliminary results suggest that SPGJ-BEE provides an improved long-term quality of life and the early induction of subsequent chemotherapy related with a better prognosis in patients with GOO.